WebDoctor Encyclopedia

Soft-tissue sarcomas

Extraskeletal osteosarcoma

Extraskeletal osteosarcoma is a rare soft tissue sarcoma that makes bone material without being attached to a bone. It mostly affects older adults, usually in the thigh, and is treated with surgery and often radiotherapy.

Medically reviewed Last reviewed October 21, 2026

What is extraskeletal osteosarcoma?

Extraskeletal osteosarcoma is a rare soft tissue cancer whose cells make bone-like material, even though the tumour is not attached to a bone. It usually grows deep in the muscles of the thigh, buttock, shoulder or back, and occasionally in organs such as the breast or bladder.

It is classed as a soft tissue sarcoma. Sarcomas are cancers of the body’s connective tissues, such as muscle, fat, nerves and bone. Only around 1-2% of soft tissue sarcomas are of this type.

The disease mostly affects older adults, usually in their 50s and 60s. It is an aggressive cancer: around one in five people already have spread to other organs when it is found, and about half of those treated for localised disease have a recurrence (Longhi et al., 2017; Heng et al., 2020).

How it differs from osteosarcoma of bone

Most osteosarcomas start inside a bone, as described on our page on osteosarcoma. Extraskeletal osteosarcoma makes the same kind of bone material, but it behaves differently.

Feature Osteosarcoma of bone Extraskeletal osteosarcoma
Where it starts Inside a bone, often near the knee or shoulder In soft tissue, away from bone
Typical age Children, teenagers and young adults Mostly adults over 40
Link to radiotherapy Uncommon Seen in a minority
Standard chemotherapy Well established Role debated
Response to chemotherapy Often good Less predictable

1. Key facts at a glance

Feature Details
Type of cancer High-grade soft tissue sarcoma that forms bone material
How common Very rare
Typical age Usually 50-70 years; rare in children
Common sites Deep soft tissue of the thigh, buttock, shoulder and back
Risk factors Previous radiotherapy in some; usually no cause found
Main treatment Wide surgical removal
Other treatments Radiotherapy; chemotherapy in selected patients
Common spread Lungs, followed by lymph nodes, bone and liver
Outlook About half alive at five years

2. Types

By microscopic pattern

Subtype Description
Osteoblastic Mostly bone-forming cells
Chondroblastic Contains cartilage-like areas
Fibroblastic Mostly spindle cells with bone material
Telangiectatic Blood-filled spaces
Small cell Small round cells; rare
Well-differentiated Low-grade; very rare at this site

By origin

Origin Notes
Primary (de novo) Most cases; no known cause
After radiotherapy Arises in an area treated with radiation years earlier
In other organs Rare cases in the breast, bladder, lung or other organs

3. Causes and risk factors

Factor Notes
Age Mostly older adults
Sex Both men and women are affected
Previous radiotherapy Can develop many years later in the treated area
Trauma Often recalled, but no proven cause
Inherited syndromes Li-Fraumeni syndrome raises sarcoma risk in general
Genetic changes in the tumour Complex changes, often involving TP53, RB1 and CDKN2A

Why does it occur in older adults?

Osteosarcoma of bone usually appears during the growth spurt, when bones are developing quickly. Extraskeletal osteosarcoma has no link to growth and instead seems to follow the pattern of other soft tissue sarcomas, which become more common with age. Researchers think it arises from primitive connective tissue cells that are able to make bone, but the exact cell of origin is unknown.

4. How does it look

On scans

Scan Typical findings
X-ray A soft tissue mass with patchy or cloud-like calcification, not attached to bone
CT Shows mineralised areas, often denser in the centre of the mass
MRI Deep, mixed-signal mass, sometimes with bleeding or dead tissue
PET-CT Helps detect spread

A review of imaging noted that the calcified mass can be confused with myositis ossificans, a harmless bone-forming reaction in muscle after injury (Hesni et al., 2023). In myositis ossificans, bone forms first at the edge of the lesion, while in extraskeletal osteosarcoma it is often more central.

Under the microscope

Feature Description
Malignant cells Large, irregular cells with abnormal nuclei
Osteoid Lace-like bone matrix made directly by the cancer cells
Cartilage Present in some tumours
Mitoses Frequent, showing rapid division
Bone attachment Absent, which separates it from osteosarcoma of bone

Size and location

Most tumours are deep, below the fascia that covers the muscles. In a 370-patient study of localised disease, eight in ten were deep tumours (Heng et al., 2020). They are often 5-10 cm or more when found, because deep lumps can grow unnoticed.

5. Symptoms

Common symptoms

  • A growing lump, usually in the thigh, buttock or shoulder
  • Pain or tenderness in some patients
  • Swelling of the affected limb

Less common symptoms

Symptom Possible cause
Limp or reduced movement Large tumour near a joint
Numbness or tingling Pressure on a nerve
Leg swelling Pressure on veins or lymph vessels
Cough or breathlessness Spread to the lungs
Weight loss and tiredness Advanced disease

Why diagnosis is often delayed

Deep lumps in the thigh or buttock may not be visible, and they are often painless at first. Many people put them down to a pulled muscle or a bruise. By the time a scan is done, the tumour may already be large.

When to seek medical advice

Lumps that are larger than 5 cm, deep, growing or painful should be checked promptly with a scan. These are the warning signs used in sarcoma referral guidelines.

6. Diagnosis

Step What is done
Examination Size, depth and mobility of the lump
Ultrasound First test for many soft tissue lumps
MRI Detailed image of the mass
CT Shows calcification; CT of the chest checks the lungs
Core needle biopsy Taken at a sarcoma centre along a track the surgeon can remove
Pathology review Specialist sarcoma pathologist
PET-CT or bone scan Staging in some patients

Staging

Extraskeletal osteosarcoma is staged with the soft tissue sarcoma TNM system. All of these tumours are treated as high grade.

Stage Simplified meaning
Stage II High-grade tumour up to 5 cm, no spread
Stage III High-grade tumour larger than 5 cm, or spread to nearby nodes
Stage IV Distant spread

In the European study of 266 patients, about 19% had metastases at diagnosis (Longhi et al., 2017).

7. Treatment

Treatment should take place at a specialist sarcoma centre.

Surgery

Aspect Details
Aim Remove the tumour with a margin of healthy tissue
Limb-sparing surgery Possible in most patients
Amputation Rarely needed
Reconstruction Flaps or grafts if large areas are removed

Almost all patients with localised disease in the European study had surgery, and clear margins were achieved in about seven in ten (Longhi et al., 2017).

Radiotherapy

Timing Purpose
Before surgery Shrinks the tumour and may make surgery easier
After surgery Lowers the risk of regrowth, especially with close margins
For symptom relief Painful metastases

In a large international study, radiotherapy was linked to a lower rate of local recurrence, though not to longer survival (Heng et al., 2020).

Chemotherapy

The role of chemotherapy is debated. Studies give different answers.

Study Main finding
European, 266 patients Chemotherapy linked to better survival, with a trend favouring osteosarcoma-type regimens containing doxorubicin, ifosfamide and cisplatin (Longhi et al., 2017)
International, 370 patients Chemotherapy did not lower the risk of distant spread or improve survival (Heng et al., 2020)
Mayo Clinic, 43 patients Regimens including platinum were linked to much longer survival (Paludo et al., 2018)

Many teams now discuss chemotherapy case by case, considering the patient’s age, fitness and tumour size. Osteosarcoma-type regimens are often preferred when chemotherapy is used.

Why do studies disagree about chemotherapy?

All the available studies look back at patients treated over several decades, at many centres and with different drugs. Patients who received chemotherapy were often younger and fitter, which can make the treatment look more effective than it really is. No randomised trial has compared chemotherapy with no chemotherapy in this disease. A shared decision with your sarcoma oncologist, weighing likely benefit against side effects, is therefore important.

Treatment of advanced disease

Situation Options
A few lung nodules Surgical removal or stereotactic radiotherapy
Widespread disease Chemotherapy, such as doxorubicin-based or cisplatin-based regimens
Clinical trials Recommended where available
Symptom control Palliative radiotherapy and supportive care

Side effects

Treatment Possible side effects
Surgery Wound healing problems, weakness, stiffness
Radiotherapy Skin reactions, wound complications if given before surgery, fibrosis, limb swelling
Doxorubicin Hair loss, low blood counts, heart effects
Cisplatin Hearing loss, kidney effects, sickness, numbness
Ifosfamide Kidney and bladder effects, confusion

8. Outlook (prognosis)

Study Five-year survival
European, all 266 patients About 47%
European, metastatic at diagnosis About 27%
International, localised disease About 56%

Factors that affect the outlook

Factor Effect
Tumour size Smaller tumours do better
Age Patients aged 40 or under did better in the European study
Margins Clear margins lower the risk of local recurrence
Metastases at diagnosis Poorer outlook

In the international study, almost half of patients had a recurrence, most often as distant spread to the lungs (Heng et al., 2020). Local regrowth was less common.

9. Follow-up

Period Typical checks
Years 1-3 Clinic visit and chest imaging every 3-4 months; MRI of the site as advised
Years 4-5 Every 6 months
After 5 years Yearly

10. Living with extraskeletal osteosarcoma

  • Follow your physiotherapy programme to rebuild strength
  • Report new lumps, cough or breathlessness without delay
  • Look after the treated skin if you had radiotherapy
  • Keep active within your limits
  • Ask for hearing and heart checks if you had cisplatin or doxorubicin
  • Seek support from sarcoma charities

Recovery after surgery

Period What to expect
First days Pain control, wound care, getting out of bed
2-6 weeks Wound healing; gentle exercises
6-12 weeks Increasing activity and strength work
3-6 months Return to most usual activities

Coping with a rare cancer

Being diagnosed with a cancer that few people have heard of can feel lonely. Sarcoma specialist nurses can explain what to expect, coordinate your appointments and help with practical problems such as work, travel and money. National sarcoma charities run helplines and online groups where you can talk with others who have had similar treatment.

Some people find it helpful to bring a family member or friend to appointments, to write down questions in advance and to ask for written summaries of what was discussed.

11. Frequently asked questions

Question Answer
Is it bone cancer? It makes bone material but starts in soft tissue, so it is treated as a soft tissue sarcoma
Did an injury cause it? No; an injury may draw attention to a lump that was already there
Will I need chemotherapy? Possibly; the decision depends on your age, fitness and tumour
Can it be cured? Yes, many people with localised disease are cured with surgery and radiotherapy
Will my limb work normally? Most people regain good function, though some weakness may remain
Should I avoid exercise? No; regular, gentle activity helps recovery, but ask about any restrictions after surgery
How quickly does it grow? Usually over weeks to months, which is why a growing lump needs prompt checks
Can radiotherapy cause it? Rarely, many years after treatment for another cancer

12. Questions to ask your care team

  • Is my tumour attached to bone, or entirely in soft tissue?
  • Has it spread to my lungs or elsewhere?
  • Will you give radiotherapy before or after surgery?
  • Do you recommend chemotherapy for me, and which kind?
  • What will my recovery look like?
  • How often will I have scans?
  • Is there a clinical trial for me?
  • Who is my key worker in the sarcoma team?
  • What symptoms should make me call you between visits?

Resources

  1. Heng, M. et al. (2020) ‘The role of chemotherapy and radiotherapy in localized extraskeletal osteosarcoma’, European Journal of Cancer, 125, pp. 130-141.
  2. Hesni, S. et al. (2023) ‘Extra-skeletal osteosarcoma: a review’, Skeletal Radiology, 52(4), pp. 633-648.
  3. Longhi, A. et al. (2017) ‘Extraskeletal osteosarcoma: a European Musculoskeletal Oncology Society study on 266 patients’, European Journal of Cancer, 74, pp. 9-16.
  4. Paludo, J. et al. (2018) ‘Extraskeletal osteosarcoma: outcomes and the role of chemotherapy’, American Journal of Clinical Oncology, 41(9), pp. 832-837.
  5. National Cancer Institute (2026) Soft Tissue Sarcoma Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/soft-tissue-sarcoma/hp/adult-soft-tissue-treatment-pdq (Accessed: October 2026).
  6. National Cancer Institute (2026) Osteosarcoma and Undifferentiated Pleomorphic Sarcoma of Bone Treatment (PDQ) – Health Professional Version. Available at: https://www.cancer.gov/types/bone/hp/osteosarcoma-treatment-pdq (Accessed: October 2026).

Prepared by the editorial team, October 2026.